Sinefungin-PLGA nanoparticles: Drug loading, Characterization, In vitro drug release and in vivo studies

Journal of Nanoscience and Nanotechnology

Volumn 9, Issue 1, 2009, Pages 150-158

  Kalimouttou, Sendilcoumare ^a   Skiba, Mohamed ^a   Bon, Pierre ^a   Dechelotte, Pierre ^b   Arnaud, Philippe ^c   Lahiani Skiba, Malika ^a  

^a Institut Fédératif de Recherches Multidisciplinaires Sur Les Peptides   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c UNIV PARIS SUD   (France)

Author keywords

Cryptosporidiosis; PLGA nanoparticles; Sinefungin

Indexed keywords

BILE DUCTS; CHRONIC INFECTION; CONCENTRATION OF; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DILUTION TECHNIQUE; DOSE-DEPENDENT; DRUG CARRIER; DRUG CONTENT; DRUG ENTRAPMENT; DRUG LOADING; DRUG SOLUTIONS; HYDROPHILIC DRUGS; IN-VITRO; IN-VIVO; OPTIMAL FORMULATION; PHYSICO-CHEMICAL CHARACTERIZATION; PLGA NANOPARTICLES; SINEFUNGIN; TOXIC EFFECT;

ADSORPTION; BODY FLUIDS;

NANOPARTICLES;

ADENOSINE; DRUG DERIVATIVE; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SINEFUNGIN;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG FORMULATION; MALE; MATERIALS TESTING; METHODOLOGY; PARTICLE SIZE; RAT; ULTRASTRUCTURE; WISTAR RAT;

ADENOSINE; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; LACTIC ACID; MALE; MATERIALS TESTING; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; RATS; RATS, WISTAR;

EID: 66649093637     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2009.J018     Document Type: Article

References (49)

1. T. Fahey, Prim Care Update Ob/Gyns 10, 75 (2003).
2. W. L. Current and L. S. Garcia, Clin. Microbiol. Rev. 4, 325 (1991).
3. P. Brasseur, D. Lemeteil, and E. Mallet, Presse Med. 16, 177 (1987).
4. W. L. Current, N. Engl. J. Med. 309, 1326 (1983).
5. N. C. Reese, W. L. Current, J. V. Ernst, and W. S. Bailey, Am. J. Trop. Med. Hyg. 31, 226 (1982).
6. S. Tzipori, Adv. Parasitol. 40, 187 (1998).
7. B. L. Blagburn, R. Soave, Prophylaxis and chemotherapy: Human and animal. Cryptosporidium and Cryptosporidiosis, edited by R. Fayer, CRC Press, Inc., New York (1997), pp. 111-128
8. P. Brasseur, D. Lemeteil, and J. J. Ballet, J. Prolozool. 38, 230s (1991).
9. D. Lemeteil, F. Roussel, L. Favennec, J. J. Ballet, and P. Brasseur, J. Infect. Dis. 67, 766 (1993).
10. R. Verdon, J. Polinski, C. Gaubdebou, C. Marche, L. Garry, and J. J. Pocidalo, Antimicrob. Agents Chemother. 38, 1681 (1994).
11. P. Brasseur, L. Favennec, D. Lemeteil, F. Roussel, and J. J. Ballet, Folia Parasitologica 41, 13 (1994).
12. T. A. Godwin, Human Pathology 22, 12-15 (1991).
13. R. L. Hamill and M. M. Hoehn, J. Antibiot. 26, 463 (1973).
14. R. S. Gordee and T. F. Butler, J. Antibiot. 26, 466 (1973).
15. M. P. Geze, P. Blanchard, J. L. Fourrey, and M. Robert-Gero, J. Am. Chem. Soc. 105, 7683 (1983).
16. U. Bacharach, L. F. Schnur, J. El-On, C. L. Greenbalt, E. Permian, M. Robert-Gero, and E. Lederer, FEBES Lett. 121, 287 (1980).
17. A. Ferrante, L. Ljungstrom, G. Huldt, and E. Lederer, Entamoeba histolytica. Trans R. Soc. Trop. Med. Hyg. 78, 837 (1984).
18. A. Ferrante, I. Ljungstrom, and E. Lederer, C.R. Acad. Sci. Ill 306, 109 (1988).
19. G. Gargala, A. Delauney, L. Favennec, P. Brasseur, and J. J. Ballet, Intern. J. Parasitol. 29, 703 (1999).
20. B. Goldberg, D. Rattendi, D. Lloyd, J. R. Sufrin, and C. J. Bacchi, Biochem. Pharmacol. 56, 95 (1998).
21. E. Messika, J. Golensr, L. Abhu-Elheiga, M. Robert-Gero, E. Ledrer, and U. Bachrach, Trop. Med. Parasitol. 41, 273 (1990).
22. P. Paolantonacci, F. Lawrence, and M. Robert-Gero, Antimicrob. Agents Chemother. 28, 528 (1985).
23. L. L. Nolan, Antimicrob. Agents Chemother. 31, 1542 (1987).
24. D. K. Dube, G. Mpimbaza, A. C. Allison, L. Ledrer, and L. Rovis, Am. J. Trop. Med. Hyg. 32, 31 (1983).
25. C. S. G. Pugh, R. T. Borchardt, and H. O. Stone, J. Biol. Chem. 253, 4075 (1978).
26. C. S. G. Pugh, R. T. Borchardt, and H. O. Stone, Biochem. 16, 3928 (1997).
27. W. K. Long, G. E. Fronko, R. G. Lindemeyer, B. Wu, and E. E. Henderson, J. Virol. 61, 221 (1987).
28. K. Shinkai, M. Mukai, T. Horai, H. Ohigashi, S. Nishikawa, H. Inoue, Y. Takeda, and H. Akedo, Jpn. J. Cancer. Res. 80, 716 (1989).
29. C. Tharasse-Bloch, P. Brasseur, L. Favennec, and J. Marchand, J. Chrom. B 674, 247 (1995).
30. E. Zweygarth, D. Schillinger, W. Kaufmann, and D. Rotcher, Trop. Med. Parasitol. 37, 255 (1986).
31. R. A. Neal, M. V. Iwobi, and M. Robert-Gero, Acad. Sci. Paris t. 308 Sene III, 485 (1989).
32. P. Couvreur and C. Vauthier, Nanoparticles: Therapeutic applications and prospects. Drugabsorption Enhancement. Concepts, Limitations and Trends, edited by A. G. de Boer, Harwood Academic Publishers, Leiden, Amsterdam, (1994), pp. 457-186.
33. L. Grislain, P. Couvreur, V. Lenaerts, M. Roland, D. Deprez-Decampeneere, and P. Speiser, Int. J. Pharm. 15, 335 (1983).
34. S. Becker, Adv. Drug. Deliv. Rev. 2, 1 (1988).
35. L. Brannon-Peppas, Int. J. Pharm. 116, 1 (1995).
36. M. Lahiani-Skiba, F. Bounoure, P. A. Shawky-Tous, and M. Skiba, J. Pharm. Biomed. Anal. 41, 1017 (2006).
37. B. Magenheim, M. Y. Levy, and S. Benita, Int. J. Pharm. 94, 115 (1993).
38. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Int. J. Pharm. 55, R1 (1989).
39. C. Washington, Int. J. Pharm. 56, 71 (1989).
40. T. Govender, S. Stolnik, M. C. Garnett, L. Ilium, and S. S. Davis, J. Control. Release 57, 185 (1999).
41. J. M. Rodrigues, H. Fessi, C. Bories, F. Puisieux, and J. P. Devissaguet, Int. J. Pharm. 126, 253 (1995).
42. S. E. Dunn, A. G. A. Coombes, M. C. Garnett, S. S. Davis, M. C. Davies, and L. Ilium, J. Control. Release 44, 65 (1997).
43. S. De Chasteigner, H. Fessi, J. P. Devissaguet, and F. Puisieux, Drug Dev. Res. 38, 125 (1996).
44. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Control. Release 25, 89 (1993).
45. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Pharm. Sci. 83, 727 (1994).
46. S. Stolnik, M. C. Garnett, M. C. Davies, L. Ilium, M. Bousta, and S. S. Davis, Coll. Surf. 97, 245 (1995).
47. H. M. Redhead, S. S. Davis, and L. Ilium, J. Control. Release 70, 353 (2001).
48. T. Texeira, M. J. Alonso, M. M. M. Pinto, and C. M. Barbosa, Europ J. Pharm. Biopharm. 59, 491 (2005).
49. P. Brasseur, D. Lemeteil, and J. J. Ballet, Antimicrob Agents Chemother. 37, 889 (1993).